Nondestructive monitoring of tissue-engineered constructs

Abstract Tissue engineering as a multidisciplinary field enables the development of living substitutes to replace, maintain, or restore diseased tissue and organs. Since the term was introduced in medicine in 1987, tissue engineering strategies have experienced significant progress. However, up to now, only a few substitutes were able to overcome the gap from bench to bedside and have been successfully approved for clinical use. Substantial donor variability makes it difficult to predict the quality of tissue-engineered constructs. It is essential to collect sufficient data to ensure that poor or immature constructs are not implanted into patients. The fulfillment of certain quality requirements, such as mechanical and structural properties, is crucial for a successful implantation. There is a clear need for new nondestructive and real-time online monitoring and evaluation methods for tissue-engineered constructs, which are applicable on the biomaterial, tissue, cellular, and subcellular levels. This paper reviews current established nondestructive techniques for implant monitoring including biochemical methods and noninvasive imaging.

[1]  Sanjiv S Gambhir,et al.  PET of vascular endothelial growth factor receptor expression. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  J. Fisher,et al.  A novel and non-destructive method to examine meniscus architecture using 9.4 Tesla MRI , 2010, Osteoarthritis and cartilage.

[3]  S. Achenbach,et al.  Detection of Calcified and Noncalcified Coronary Atherosclerotic Plaque by Contrast-Enhanced, Submillimeter Multidetector Spiral Computed Tomography: A Segment-Based Comparison With Intravascular Ultrasound , 2003, Circulation.

[4]  E. Brown,et al.  Virulence potential of the staphylococcal adhesin CNA in experimental arthritis is determined by its affinity for collagen. , 2004, The Journal of infectious diseases.

[5]  Dario Neri,et al.  Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  Ville Ellä,et al.  Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. , 2010, Biomaterials.

[7]  Fabian Kiessling,et al.  Iron Oxide‐Labeled Collagen Scaffolds for Non‐Invasive MR Imaging in Tissue Engineering , 2014, Advanced functional materials.

[8]  Maarten Merkx,et al.  Fluorescently labeled collagen binding proteins allow specific visualization of collagen in tissues and live cell culture. , 2006, Analytical biochemistry.

[9]  Fabian Kiessling,et al.  Virtual elastic sphere processing enables reproducible quantification of vessel stenosis at CT and MR angiography. , 2011, Radiology.

[10]  D G Pavel,et al.  Rapid miniaturized chromatographic quality-control procedures for Tc-99m radiopharmaceuticals. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  G. Moneta,et al.  Diagnostics of “non-acute” vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses , 2010 .

[12]  Mohammad Sib Ansari,et al.  Fluorinated COX-2 Inhibitors as Agents in PET Imaging of Inflammation and Cancer , 2011, Cancer Prevention Research.

[13]  K. König,et al.  Two-photon microscopes and in vivo multiphoton tomographs--powerful diagnostic tools for tissue engineering and drug delivery. , 2006, Advanced drug delivery reviews.

[14]  Julien Sénégas,et al.  A Concept for Magnetic Resonance Visualization of Surgical Textile Implants , 2010, Investigative radiology.

[15]  E Wintermantel,et al.  Vascular tissue engineering with magnetic nanoparticles: seeing deeper , 2007, Journal of tissue engineering and regenerative medicine.

[16]  Marina V Backer,et al.  Molecular Imaging of Vascular Endothelial Growth Factor Receptors in Graft Arteriosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[17]  W J Montgomery,et al.  Detection of osteomyelitis at fracture nonunion sites: comparison of two scintigraphic methods. , 1989, AJR. American journal of roentgenology.

[18]  V. Préat,et al.  RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. , 2012, Molecular pharmaceutics.

[19]  L. Crofford,et al.  COX-1 and COX-2 tissue expression: implications and predictions. , 1997, The Journal of rheumatology. Supplement.

[20]  William C. Eckelman,et al.  First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer , 2013, The Journal of Nuclear Medicine.

[21]  Kristi S. Anseth,et al.  An Instrumented Bioreactor for Mechanical Stimulation and Real-Time, Nondestructive Evaluation of Engineered Cartilage Tissue , 2012 .

[22]  T. Schmitz-Rode,et al.  Generation and imaging of patient customized implants , 2012 .

[23]  Laura Marcu,et al.  Noninvasive multimodal evaluation of bioengineered cartilage constructs combining time-resolved fluorescence and ultrasound imaging. , 2011, Tissue engineering. Part C, Methods.

[24]  Ivan Stamenkovic,et al.  Functional structure and composition of the extracellular matrix , 2003, The Journal of pathology.

[25]  W. Grizzle,et al.  Special symposium: fixation and tissue processing models , 2009, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[26]  K. König,et al.  Multiphoton autofluorescence imaging of intratissue elastic fibers. , 2005, Biomaterials.

[27]  Ora Israel,et al.  Prosthetic Vascular Graft Infection: The Role of 18F-FDG PET/CT , 2007, Journal of Nuclear Medicine.

[28]  Maarten Merkx,et al.  High resolution imaging of collagen organisation and synthesis using a versatile collagen specific probe. , 2007, Journal of structural biology.

[29]  Yves D'Asseler,et al.  99mTc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature , 2012, The Journal of Nuclear Medicine.

[30]  Heike Walles,et al.  Raman spectroscopy in biomedicine – non-invasive in vitro analysis of cells and extracellular matrix components in tissues , 2012, Biotechnology journal.

[31]  Thomas Schmitz-Rode,et al.  Nondestructive method to evaluate the collagen content of fibrin-based tissue engineered structures via ultrasound. , 2011, Tissue engineering. Part C, Methods.

[32]  H. Cheng,et al.  Monitoring tissue development in acellular matrix‐based regeneration for bladder tissue engineering: Multiexponential diffusion and T2* for improved specificity , 2012, NMR in biomedicine.

[33]  Fabian Kiessling,et al.  FMN-coated fluorescent iron oxide nanoparticles for RCP-mediated targeting and labeling of metabolically active cancer and endothelial cells. , 2011, Biomaterials.

[34]  Roland Hustinx,et al.  18F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3 , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  L Csernay,et al.  Leukocyte scintigraphy to assess disease activity in inflammatory bowel disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  M. Thakur,et al.  Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. II. Particles. , 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  G Tellides,et al.  Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue‐engineered vascular grafts in vivo , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  Kimberlee Potter,et al.  Non-destructive studies of tissue-engineered phalanges by magnetic resonance microscopy and X-ray microtomography. , 2006, Bone.

[39]  David L. Kaplan,et al.  Non-Invasive Time-Lapsed Monitoring and Quantification of Engineered Bone-Like Tissue , 2007, Annals of Biomedical Engineering.

[40]  Paul Watts,et al.  Microfluidics in radiopharmaceutical chemistry. , 2013, Nuclear medicine and biology.

[41]  T. Croll,et al.  Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential. , 2007, Regenerative medicine.

[42]  P. Koolwijk,et al.  Role of Fibrin Matrix in Angiogenesis , 2001, Annals of the New York Academy of Sciences.

[43]  H. Herzog,et al.  In vivo functional imaging with SPECT and PET , 2001 .

[44]  Fabian Kiessling,et al.  Non-invasive Imaging of Tissue-Engineered Vascular Endothelium with Iron Oxide Nanoparticles , 2012 .

[45]  P. Wells.  Ultrasonics in medicine and biology. , 1977, Physics in medicine and biology.

[46]  Thomas Schmitz-Rode,et al.  In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. , 2009, Tissue engineering. Part A.

[47]  Karsten König,et al.  Imaging of cardiovascular structures using near-infrared femtosecond multiphoton laser scanning microscopy. , 2005, Journal of biomedical optics.

[48]  T. Schmitz-Rode,et al.  Non-Destructive Analysis of Extracellular Matrix Development in Cardiovascular Tissue-Engineered Constructs , 2013, Annals of Biomedical Engineering.

[49]  P. Libby,et al.  Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. , 1993, The Journal of clinical investigation.

[50]  M. Ansar,et al.  A comparative study of aggrecan synthesis between natural articular chondrocytes and differentiated chondrocytes from adipose derived stem cells in 3D culture , 2012, Advanced biomedical research.

[51]  Nikolaus Thierfelder,et al.  Noninvasive Analysis of Synthetic and Decellularized Scaffolds for Heart Valve Tissue Engineering , 2013, ASAIO journal.

[52]  Olli Simell,et al.  An autoradiographic study of [(18)F]FDG uptake to islets of Langerhans in NOD mouse. , 2005, Diabetes Research and Clinical Practice.

[53]  J. Xu,et al.  Increased expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in rat cardiac allografts. , 2008, Transplantation proceedings.

[54]  T C Flanagan,et al.  Living artificial heart valve alternatives: a review. , 2003, European cells & materials.

[55]  Dietmar Werner Hutmacher,et al.  Application of micro CT and computation modeling in bone tissue engineering , 2005, Comput. Aided Des..

[56]  Hiroshi Fukuda,et al.  Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor. , 2003, Nuclear medicine and biology.

[57]  Ralph Weissleder,et al.  18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. , 2009, JACC. Cardiovascular imaging.

[58]  Lawrence J Marnett,et al.  Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents. , 2010, Cancer research.

[59]  M. Thakur,et al.  Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. I. Soluble agents. , 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  Pat Zanzonico,et al.  Principles of Nuclear Medicine Imaging: Planar, SPECT, PET, Multi-modality, and Autoradiography Systems , 2012, Radiation research.

[61]  Hajime Ohgushi,et al.  Osteocalcin secretion as an early marker of in vitro osteogenic differentiation of rat mesenchymal stem cells. , 2009, Tissue engineering. Part C, Methods.

[62]  Paul Watts,et al.  Radiochemistry on chip: towards dose-on-demand synthesis of PET radiopharmaceuticals. , 2013, Lab on a chip.

[63]  Victor E Reuter,et al.  Prostate-specific membrane antigen expression in regeneration and repair , 2008, Modern Pathology.

[64]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[65]  Didier Merlin,et al.  ADAM‐15: a metalloprotease that mediates inflammation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  George Sgouros,et al.  Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer , 2012, The Journal of Nuclear Medicine.

[67]  Zheng Fu,et al.  Imaging proliferation of 18F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[68]  Dario Neri,et al.  Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin , 2001, European Journal of Nuclear Medicine.

[69]  Tomokazu Numano,et al.  Feasibility of noninvasive evaluation of biophysical properties of tissue-engineered cartilage by using quantitative MRI. , 2007, Journal of biomechanics.

[70]  Ulrich Meyer,et al.  The History of Tissue Engineering and Regenerative Medicine in Perspective , 2009 .

[71]  Justin S. Weinbaum,et al.  Monitoring collagen transcription by vascular smooth muscle cells in fibrin-based tissue constructs. , 2010, Tissue engineering. Part C, Methods.

[72]  Kristi S Anseth,et al.  Ultrasound monitoring of cartilaginous matrix evolution in degradable PEG hydrogels. , 2009, Acta biomaterialia.

[73]  Seung Hyun Lee,et al.  Growth and Switching Options in Foreign Direct Investment. , 2008 .

[74]  Lawrence J. Marnett,et al.  [123I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation , 2010, ACS medicinal chemistry letters.

[75]  Alan J. Russell,et al.  Moving into the Clinic , 2014 .